Conference Coverage

Apixiban for VTE reduces subsequent hospitalizations

Publish date: April 17, 2014

 

AT ACC 14

The AMPLIFY trial was sponsored by Bristol-Myers Squibb and Pfizer. Dr. Johnson reported having no financial conflicts.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

FDA expands uses for cardiac resynchronization devices
MDedge Family Medicine
ACC/AHA cardiovascular risk equations get a thumbs-up
MDedge Family Medicine
Intervention manages cardiac patients with depression, anxiety
MDedge Family Medicine
Post-MI beta-blockers: Less is more
MDedge Family Medicine
Diet, exercise in prediabetes may prevent long-term progression and mortality
MDedge Family Medicine
Insertable monitor reveals AF in 30% of cryptogenic stroke patients
MDedge Family Medicine
Life partner provides better heart failure outcomes
MDedge Family Medicine
Complication rates decline among diabetes patients
MDedge Family Medicine
When low HDL means ‘no sweat’
MDedge Family Medicine
Marriage protects against vascular disease
MDedge Family Medicine